Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Christina Aquilante

Concepts (357)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacogenetics
30
2025
180
6.350
 Why?
Pharmacogenomic Testing
15
2025
64
4.400
 Why?
Thiazolidinediones
8
2016
137
2.670
 Why?
Aryl Hydrocarbon Hydroxylases
10
2014
48
2.330
 Why?
Heart Transplantation
9
2024
755
2.210
 Why?
Polymorphism, Genetic
17
2019
660
2.100
 Why?
Organ Transplantation
3
2024
251
1.730
 Why?
Cytochrome P-450 CYP3A
8
2024
88
1.640
 Why?
Precision Medicine
11
2025
433
1.570
 Why?
Genotype
20
2025
1917
1.490
 Why?
Tacrolimus
3
2024
200
1.440
 Why?
Polymorphism, Single Nucleotide
11
2024
2189
1.440
 Why?
Cytochrome P-450 CYP2C19
6
2024
25
1.360
 Why?
Health Personnel
4
2021
711
1.290
 Why?
Hypoglycemic Agents
11
2020
1294
1.260
 Why?
Transplant Recipients
6
2024
184
1.230
 Why?
Decision Support Systems, Clinical
2
2024
236
1.180
 Why?
Graft Rejection
3
2024
624
1.090
 Why?
Blood Pressure
8
2020
1789
1.070
 Why?
Metabolic Syndrome
4
2016
354
1.040
 Why?
Cytochrome P-450 CYP2D6
4
2022
30
1.010
 Why?
Pharmacists
3
2022
265
0.900
 Why?
Immunosuppressive Agents
6
2024
894
0.890
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2024
445
0.790
 Why?
Cost-Benefit Analysis
3
2024
593
0.770
 Why?
Gemfibrozil
2
2013
11
0.750
 Why?
Sulfonylurea Compounds
3
2018
48
0.720
 Why?
Leukopenia
1
2021
31
0.720
 Why?
Hepatocyte Nuclear Factor 1-alpha
1
2021
20
0.720
 Why?
Adiponectin
2
2016
244
0.710
 Why?
Hypolipidemic Agents
2
2013
91
0.710
 Why?
Warfarin
4
2024
154
0.700
 Why?
Mycophenolic Acid
1
2021
118
0.680
 Why?
Organic Anion Transporters
2
2011
12
0.670
 Why?
Desogestrel
5
2021
46
0.670
 Why?
Biological Specimen Banks
2
2024
102
0.660
 Why?
Platelet Aggregation Inhibitors
1
2024
463
0.660
 Why?
Humans
82
2025
137782
0.620
 Why?
Hypertension
3
2020
1298
0.620
 Why?
Prescription Drugs
2
2020
109
0.610
 Why?
Cytochrome P-450 CYP2C8
7
2014
15
0.600
 Why?
Cardiologists
1
2018
45
0.590
 Why?
Adult
43
2024
38023
0.590
 Why?
Middle Aged
41
2024
33554
0.580
 Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2021
47
0.560
 Why?
HIV Protease Inhibitors
4
2016
69
0.550
 Why?
Physicians
3
2021
914
0.550
 Why?
Ritonavir
4
2012
74
0.530
 Why?
Academic Medical Centers
1
2020
512
0.520
 Why?
Male
48
2024
67906
0.510
 Why?
Female
52
2024
73465
0.510
 Why?
Polypharmacy
1
2017
85
0.500
 Why?
Heart Failure
4
2017
2237
0.500
 Why?
Lectins
1
2016
49
0.490
 Why?
Nonprescription Drugs
1
2016
63
0.490
 Why?
Antiviral Agents
1
2021
744
0.470
 Why?
Attitude of Health Personnel
2
2020
1172
0.460
 Why?
Dihydrouracil Dehydrogenase (NADP)
2
2025
2
0.460
 Why?
Dihydropyrimidine Dehydrogenase Deficiency
2
2025
2
0.460
 Why?
Cytochrome P-450 Enzyme System
2
2006
155
0.450
 Why?
Medicare
1
2020
773
0.440
 Why?
Death, Sudden, Cardiac
3
2021
185
0.440
 Why?
Contraceptive Agents, Female
3
2020
80
0.440
 Why?
Pediatrics
2
2021
1103
0.420
 Why?
Chemokine CXCL5
3
2012
11
0.400
 Why?
Blood Pressure Determination
1
2014
157
0.400
 Why?
Arrhythmias, Cardiac
3
2021
333
0.400
 Why?
Heptanoic Acids
1
2013
66
0.400
 Why?
Anticoagulants
3
2024
664
0.380
 Why?
Pyrazines
1
2013
90
0.380
 Why?
Resistin
2
2010
11
0.370
 Why?
Pharmaceutical Preparations
3
2009
179
0.370
 Why?
Pravastatin
1
2011
41
0.370
 Why?
Pyrroles
1
2013
213
0.370
 Why?
Triazoles
1
2013
147
0.360
 Why?
Retrospective Studies
15
2024
15682
0.360
 Why?
Diabetes Mellitus, Type 2
5
2020
2534
0.360
 Why?
Health Knowledge, Attitudes, Practice
4
2021
1330
0.350
 Why?
Dobutamine
3
2008
39
0.350
 Why?
Cross-Sectional Studies
8
2020
5478
0.340
 Why?
Managed Care Programs
2
2022
135
0.330
 Why?
Aged
19
2024
24001
0.320
 Why?
Antidepressive Agents
2
2022
236
0.320
 Why?
Mixed Function Oxygenases
2
2008
40
0.320
 Why?
DNA
1
2016
1459
0.310
 Why?
Drug Interactions
5
2017
410
0.310
 Why?
Chromatography, Liquid
1
2010
433
0.300
 Why?
Polymerase Chain Reaction
3
2006
1062
0.290
 Why?
Drug Prescriptions
4
2021
245
0.290
 Why?
Health
1
2008
84
0.280
 Why?
International Normalized Ratio
2
2024
47
0.280
 Why?
Sulfonamides
1
2011
513
0.280
 Why?
Cytokines
1
2016
2085
0.280
 Why?
Chemokine CCL2
1
2008
115
0.280
 Why?
Antimetabolites, Antineoplastic
2
2025
94
0.280
 Why?
Time Factors
8
2020
6834
0.270
 Why?
Young Adult
13
2021
13240
0.270
 Why?
Drug Implants
4
2021
82
0.270
 Why?
Receptors, Adrenergic, beta
1
2008
127
0.270
 Why?
Mass Spectrometry
1
2010
739
0.270
 Why?
Fluorouracil
2
2025
208
0.260
 Why?
Heart Rate
3
2008
824
0.260
 Why?
Matrix Metalloproteinase 8
1
2006
8
0.260
 Why?
Haplotypes
5
2013
494
0.260
 Why?
Blood Glucose
3
2016
2190
0.260
 Why?
United States
12
2025
14870
0.260
 Why?
Sequence Analysis, DNA
4
2012
812
0.260
 Why?
Vitamin K Epoxide Reductases
3
2020
12
0.250
 Why?
Metoprolol
1
2006
40
0.250
 Why?
Blood Coagulation Factors
1
2006
54
0.240
 Why?
Prospective Studies
7
2024
7623
0.240
 Why?
Clinical Laboratory Techniques
1
2006
97
0.240
 Why?
Electronic Health Records
3
2024
1070
0.240
 Why?
Autonomic Nervous System
1
2006
76
0.240
 Why?
Models, Biological
1
2013
1783
0.230
 Why?
Administration, Oral
4
2016
816
0.230
 Why?
Clinical Protocols
2
2017
271
0.230
 Why?
Capecitabine
1
2025
45
0.230
 Why?
Echocardiography
1
2008
644
0.230
 Why?
Genetic Variation
3
2019
991
0.220
 Why?
Echocardiography, Stress
1
2004
25
0.220
 Why?
Polymorphism, Restriction Fragment Length
1
2004
68
0.220
 Why?
Cross-Over Studies
3
2013
564
0.220
 Why?
Adverse Drug Reaction Reporting Systems
1
2024
77
0.220
 Why?
Adrenergic beta-Antagonists
1
2006
323
0.210
 Why?
Follow-Up Studies
5
2024
5136
0.210
 Why?
Carrier Proteins
1
2008
771
0.210
 Why?
United States Food and Drug Administration
1
2024
208
0.210
 Why?
Biotransformation
2
2013
65
0.210
 Why?
Cytochrome P-450 CYP2C9
4
2019
20
0.200
 Why?
Cohort Studies
7
2021
5750
0.200
 Why?
Metformin
1
2007
331
0.200
 Why?
Alleles
6
2012
892
0.200
 Why?
Waist Circumference
2
2016
143
0.200
 Why?
Gene Frequency
4
2013
521
0.190
 Why?
Antimalarials
2
2013
31
0.180
 Why?
Dose-Response Relationship, Drug
4
2024
2057
0.180
 Why?
Clinical Trials as Topic
1
2006
1052
0.180
 Why?
Aged, 80 and over
5
2024
7637
0.180
 Why?
Drug Dosage Calculations
1
2020
23
0.170
 Why?
Calcineurin Inhibitors
1
2021
73
0.170
 Why?
Pharmacogenomic Variants
2
2021
35
0.170
 Why?
Egypt
1
2020
11
0.170
 Why?
Antibiotics, Antineoplastic
1
2021
128
0.170
 Why?
Cytomegalovirus
1
2021
157
0.170
 Why?
Atazanavir Sulfate
3
2016
41
0.170
 Why?
Area Under Curve
2
2013
314
0.160
 Why?
No-Show Patients
1
2019
1
0.160
 Why?
Menstruation Disturbances
1
2019
13
0.160
 Why?
Diabetes Mellitus
2
2024
1041
0.160
 Why?
Brain Chemistry
1
2000
117
0.160
 Why?
Cytochrome P450 Family 3
1
2019
3
0.160
 Why?
Hemodynamics
1
2004
1113
0.150
 Why?
Colorado
3
2024
4576
0.150
 Why?
Cardiovascular Diseases
3
2024
2111
0.150
 Why?
Blood Pressure Monitoring, Ambulatory
1
2020
87
0.150
 Why?
Oligopeptides
2
2012
271
0.150
 Why?
Smoking
1
2006
1627
0.150
 Why?
Body Weight
2
2016
985
0.150
 Why?
Patients
1
2020
175
0.150
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2013
351
0.150
 Why?
Morphine
1
2000
158
0.150
 Why?
Lipids
2
2016
673
0.150
 Why?
Child Health Services
1
2020
184
0.150
 Why?
Sitagliptin Phosphate
2
2021
33
0.150
 Why?
Double-Blind Method
2
2016
1997
0.140
 Why?
Progesterone
1
2019
254
0.140
 Why?
Ventricular Dysfunction
1
2018
15
0.140
 Why?
Treatment Outcome
7
2024
10837
0.140
 Why?
Psychiatry
1
2020
180
0.140
 Why?
Body Mass Index
3
2019
2390
0.140
 Why?
Bariatric Surgery
1
2021
217
0.140
 Why?
Apyrase
1
2017
17
0.130
 Why?
Organophosphonates
2
2008
93
0.130
 Why?
Healthy Volunteers
2
2019
199
0.130
 Why?
Pyridines
2
2012
506
0.130
 Why?
DNA Primers
3
2006
515
0.130
 Why?
Pyrophosphatases
1
2016
28
0.130
 Why?
Chronic Disease
2
2017
1794
0.130
 Why?
Anti-HIV Agents
2
2016
778
0.130
 Why?
Cardiology
1
2018
274
0.120
 Why?
Circadian Rhythm
1
2020
468
0.120
 Why?
Gene Expression Regulation, Enzymologic
1
2017
283
0.120
 Why?
Depression
2
2022
1408
0.120
 Why?
GPI-Linked Proteins
1
2016
73
0.120
 Why?
Ribavirin
1
2016
91
0.120
 Why?
Patient Care
1
2016
111
0.120
 Why?
Adenine
2
2008
271
0.120
 Why?
Students, Pharmacy
1
2016
97
0.120
 Why?
Metabolic Clearance Rate
2
2013
115
0.120
 Why?
HIV Infections
4
2016
2837
0.120
 Why?
Therapeutics
1
2015
14
0.120
 Why?
Education, Pharmacy
1
2016
120
0.120
 Why?
Voriconazole
1
2015
20
0.110
 Why?
beta-Cyclodextrins
1
2015
28
0.110
 Why?
Delivery of Health Care
1
2022
951
0.110
 Why?
Patient Education as Topic
1
2019
766
0.110
 Why?
Renal Replacement Therapy
1
2015
92
0.110
 Why?
Diltiazem
1
2014
29
0.110
 Why?
Surgical Procedures, Operative
1
2017
259
0.110
 Why?
Antifungal Agents
1
2015
137
0.110
 Why?
Antigens, CD
1
2017
521
0.110
 Why?
Chromosomes, Human, Pair 10
1
2013
19
0.110
 Why?
Phenotype
3
2024
3196
0.110
 Why?
Reoperation
1
2016
573
0.100
 Why?
Adolescent
6
2021
21574
0.100
 Why?
Medication Adherence
1
2017
467
0.100
 Why?
Cardiomyopathies
1
2017
350
0.100
 Why?
Kidney Transplantation
1
2019
709
0.100
 Why?
Half-Life
1
2013
164
0.100
 Why?
Venous Thromboembolism
1
2017
316
0.100
 Why?
Sirolimus
1
2014
276
0.100
 Why?
Tissue Distribution
2
2014
332
0.090
 Why?
Liver Transplantation
1
2019
871
0.090
 Why?
Darunavir
1
2011
19
0.090
 Why?
Practice Patterns, Physicians'
1
2020
1313
0.090
 Why?
Surveys and Questionnaires
2
2024
5793
0.090
 Why?
Self Care
1
2014
380
0.090
 Why?
Genetic Association Studies
1
2013
377
0.090
 Why?
Lung Transplantation
1
2014
313
0.090
 Why?
Acquired Immunodeficiency Syndrome
1
2012
230
0.080
 Why?
Reverse Transcriptase Inhibitors
2
2008
84
0.080
 Why?
Insulin Resistance
2
2010
1211
0.080
 Why?
Genetic Testing
2
2025
462
0.080
 Why?
Prevalence
1
2017
2734
0.080
 Why?
Patient Discharge
1
2016
897
0.080
 Why?
Cholesterol
1
2011
410
0.080
 Why?
Triglycerides
1
2011
524
0.080
 Why?
ATP-Binding Cassette Transporters
1
2010
137
0.080
 Why?
Leukocytes
2
2012
311
0.080
 Why?
Kidney Failure, Chronic
1
2015
570
0.080
 Why?
Lipoproteins
1
2010
168
0.080
 Why?
Longitudinal Studies
1
2016
2860
0.070
 Why?
Risk Assessment
3
2020
3461
0.070
 Why?
Lung Diseases
1
2014
767
0.070
 Why?
Databases, Factual
3
2021
1357
0.070
 Why?
Weight Gain
2
2021
519
0.070
 Why?
Incidence
2
2020
2804
0.070
 Why?
Indinavir
1
2006
7
0.060
 Why?
Drug Delivery Systems
1
2010
365
0.060
 Why?
Pyrimidinones
1
2007
113
0.060
 Why?
Linear Models
2
2019
849
0.060
 Why?
Genetic Techniques
1
2006
64
0.060
 Why?
Zidovudine
1
2006
78
0.060
 Why?
Lamivudine
1
2006
63
0.060
 Why?
Factor X
1
2006
27
0.060
 Why?
Prothrombin
1
2006
26
0.060
 Why?
Factor VII
1
2006
24
0.060
 Why?
Reproducibility of Results
1
2014
3290
0.060
 Why?
Drug Utilization
1
2007
169
0.060
 Why?
Chemokines, CXC
1
2006
70
0.060
 Why?
Base Sequence
2
2006
2181
0.060
 Why?
Oxidation-Reduction
1
2009
1060
0.060
 Why?
C-Reactive Protein
1
2008
410
0.060
 Why?
Biomarkers
3
2014
4154
0.060
 Why?
Regression Analysis
1
2008
1024
0.060
 Why?
Prognosis
2
2014
4039
0.060
 Why?
Delayed-Action Preparations
1
2006
181
0.060
 Why?
Pharmacovigilance
1
2024
23
0.060
 Why?
Health Care Surveys
1
2007
565
0.060
 Why?
Mathematical Computing
1
2004
10
0.060
 Why?
Gene Expression Regulation
1
2014
2607
0.060
 Why?
Gene Expression
1
2009
1502
0.050
 Why?
Drug Labeling
1
2004
39
0.050
 Why?
Risk Factors
3
2020
10407
0.050
 Why?
Infusions, Intravenous
1
2004
413
0.050
 Why?
Multidrug Resistance-Associated Proteins
3
2008
38
0.050
 Why?
Laboratories
1
2004
113
0.050
 Why?
Algorithms
3
2024
1704
0.050
 Why?
Reference Values
1
2004
816
0.050
 Why?
Kidney
2
2008
1475
0.050
 Why?
Drug Monitoring
1
2024
221
0.050
 Why?
Blood Coagulation
1
2024
257
0.050
 Why?
Socioeconomic Factors
1
2007
1290
0.050
 Why?
Linagliptin
1
2021
5
0.050
 Why?
Adamantane
1
2021
18
0.050
 Why?
Administrative Claims, Healthcare
1
2021
26
0.050
 Why?
Dipeptides
1
2021
50
0.040
 Why?
Electronic Prescribing
1
2021
3
0.040
 Why?
Electrocardiography
1
2004
629
0.040
 Why?
Uterine Hemorrhage
1
2021
37
0.040
 Why?
Protective Factors
1
2020
93
0.040
 Why?
Costs and Cost Analysis
1
2020
213
0.040
 Why?
Drug Tolerance
1
2000
105
0.040
 Why?
Treatment Failure
1
2020
356
0.040
 Why?
Homozygote
2
2012
203
0.040
 Why?
Kaplan-Meier Estimate
1
2021
889
0.040
 Why?
Animals
3
2008
36951
0.040
 Why?
Sex Factors
1
2024
2077
0.040
 Why?
Genomics
1
2024
795
0.040
 Why?
Glipizide
1
2018
6
0.040
 Why?
Attitude
1
2020
259
0.040
 Why?
Antineoplastic Agents
1
2009
2129
0.040
 Why?
Proportional Hazards Models
1
2021
1266
0.040
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.040
 Why?
Glyburide
1
2018
32
0.040
 Why?
Dexamethasone
1
2000
370
0.030
 Why?
Liver
1
2006
1943
0.030
 Why?
Social Class
1
2019
282
0.030
 Why?
Feasibility Studies
1
2021
963
0.030
 Why?
Self-Management
1
2019
182
0.030
 Why?
Self Report
1
2021
829
0.030
 Why?
Membrane Transport Proteins
2
2008
162
0.030
 Why?
Anesthetics
1
2017
81
0.030
 Why?
Peru
1
2016
58
0.030
 Why?
Pharmaceutical Services
1
2016
83
0.030
 Why?
Tenofovir
2
2008
243
0.030
 Why?
Diabetic Angiopathies
1
2018
259
0.030
 Why?
Medicaid
1
2020
435
0.030
 Why?
Cause of Death
1
2018
436
0.030
 Why?
South Africa
1
2016
222
0.030
 Why?
Perioperative Care
1
2017
178
0.030
 Why?
Indians, North American
1
2021
643
0.030
 Why?
Alternative Splicing
1
2017
229
0.030
 Why?
Preoperative Care
1
2017
362
0.030
 Why?
HEK293 Cells
1
2017
730
0.030
 Why?
Hepatitis C, Chronic
1
2016
164
0.030
 Why?
Rats, Sprague-Dawley
1
2000
2487
0.030
 Why?
Receptors, Steroid
1
2014
50
0.030
 Why?
Everolimus
1
2014
91
0.030
 Why?
Demography
1
2014
291
0.030
 Why?
Hypoglycemia
1
2018
445
0.030
 Why?
Vasodilator Agents
1
2014
331
0.020
 Why?
Age Factors
1
2019
3305
0.020
 Why?
Mental Disorders
1
2020
1077
0.020
 Why?
Heterozygote
1
2012
293
0.020
 Why?
Rats
1
2000
5648
0.020
 Why?
Genetic Loci
1
2012
288
0.020
 Why?
Neoplasms
1
2024
2673
0.020
 Why?
Critical Illness
1
2015
815
0.020
 Why?
Insulin
1
2019
2411
0.020
 Why?
Multivariate Analysis
1
2012
1509
0.020
 Why?
Body Composition
1
2012
684
0.020
 Why?
Genetic Predisposition to Disease
1
2017
2427
0.020
 Why?
Plasma
1
2009
212
0.020
 Why?
Lopinavir
1
2007
30
0.020
 Why?
PubMed
1
2006
11
0.020
 Why?
Ribosomal Proteins
1
2006
93
0.020
 Why?
Antiretroviral Therapy, Highly Active
1
2007
271
0.010
 Why?
Pharmacology
1
2005
9
0.010
 Why?
Molecular Sequence Data
1
2009
2900
0.010
 Why?
Likelihood Functions
1
2005
144
0.010
 Why?
RNA, Messenger
1
2012
2834
0.010
 Why?
Cardiotonic Agents
1
2005
124
0.010
 Why?
Mitochondrial Proteins
1
2006
257
0.010
 Why?
Chromosome Mapping
1
2005
523
0.010
 Why?
Genome
1
2006
300
0.010
 Why?
Drug Therapy, Combination
1
2006
1067
0.010
 Why?
Hemorrhage
1
2008
722
0.010
 Why?
Predictive Value of Tests
1
2008
2041
0.010
 Why?
Saccharomyces cerevisiae Proteins
1
2006
405
0.010
 Why?
Models, Genetic
1
2005
600
0.010
 Why?
Pilot Projects
1
2006
1713
0.010
 Why?
Child
1
2020
21989
0.010
 Why?
Computer Simulation
1
2005
982
0.010
 Why?
Case-Control Studies
1
2007
3569
0.010
 Why?
Inflammation
1
2006
2838
0.010
 Why?
Aquilante's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (357) concept(s)
_
Co-Authors Expand Description
See all (54) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)